651 related articles for article (PubMed ID: 16307805)
1. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
[TBL] [Abstract][Full Text] [Related]
2. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
[TBL] [Abstract][Full Text] [Related]
3. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
Namdar M; Steffel J; Jetzer S; Schmied C; Hürlimann D; Camici GG; Bayrak F; Ricciardi D; Rao JY; de Asmundis C; Chierchia GB; Sarkozy A; Lüscher TF; Jenni R; Duru F; Brugada P
Am J Cardiol; 2012 Feb; 109(4):587-93. PubMed ID: 22105784
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
[TBL] [Abstract][Full Text] [Related]
6. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
[TBL] [Abstract][Full Text] [Related]
7. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
8. Amyloidosis and cardiac involvement.
Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
[TBL] [Abstract][Full Text] [Related]
9. [Echocardiographic findings of a patient with cardiac amyloidosis and left ventricular outflow obstruction].
Noma S; Akaishi M; Murayama A; Akiyama H; Ogawa S; Handa S; Nakamura Y; Sohma Y; Hosoda Y; Gotoh M
J Cardiogr; 1982 Mar; 12(1):267-78. PubMed ID: 6889625
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy: cardiac magnetic resonance may help differentiate amyloidosis from hypertrophic cardiomyopathy.
Mabru M; Dacher JN; Bauer F
Arch Cardiovasc Dis; 2010 Jan; 103(1):55-6. PubMed ID: 20142122
[No Abstract] [Full Text] [Related]
11. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study.
Sadick N; Thomas L
Heart Lung Circ; 2007 Jun; 16(3):200-6. PubMed ID: 17452128
[TBL] [Abstract][Full Text] [Related]
13. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
Roudaut R; Haissaguerre M; Dallocchio M
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1525-31. PubMed ID: 6240237
[TBL] [Abstract][Full Text] [Related]
14. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
[TBL] [Abstract][Full Text] [Related]
16. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
Kohno I; Komori S; Yamamoto K; Sano S; Ishihara T; Umetani K; Sawanobori T; Ijiri H; Tamura K
Intern Med; 2000 Aug; 39(8):637-40. PubMed ID: 10939537
[TBL] [Abstract][Full Text] [Related]
18. [Hypertrophic cardiomyopathy manifesting different modes of illness: report of three cases].
Shida M; Miyazaki Y; Matsuyama K; Iwami G; Ooga M; Chiba M; Furuta Y; Toshima H; Koga Y
J Cardiol; 1987 Mar; 17(1):187-97. PubMed ID: 3429921
[TBL] [Abstract][Full Text] [Related]
19. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
20. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
Hayashi S; Yamada H; Nishio S; Hotchi J; Bando M; Takagawa Y; Saijo Y; Hirata Y; Sata M
J Cardiol; 2015 Jun; 65(6):519-25. PubMed ID: 25199979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
